While several European and western countries are still struggling with Covid-19 cases, enforcing restrictions on social gatherings, life seems to have returned almost to normal in much of Asia, including India. There has been a surge in the reports trying to explain the low numbers in Asia, but almost all of them lack a biological mechanism behind the fall in numbers. Now, a team of Indian scientists has described a plausible mechanism responsible for the contrast in the numbers seen worldwide.
It is essential to observe a downward trajectory of cases along with low positivity rate for the successful reopening of the different parts of the country. Investment in the public health system by the government and trust in public health experts is fundamental in India’s fight against this virus, writes Dr Riddhi A. Babel (PhDc, MPH, BDS), Epidemiology PhD candidate at Rutgers School of Public Health.
With experts trying to find the possible reasons for the low COVID related death rate in India, a hypothesis by Sandeep Chakraborty has generated considerable interest because of the data based explanation it offers. Sandeep Chakraborty (B-Tech, Electrical Engineering IIT Kharagpur, 1997), (Masters. Computer science, IIT Kharagpur, 2008) is a researcher focused on computational protein modelling, genome projects, and designing anti-microbial peptides. His hypothesis based on his current research and data analysis on COVID-19 pathogenesis suggests that it's Prevotella - the anaerobic bacteria that might be responsible for the systemic complications seen in COVID-19. Another component of his hypothesis depends on data from previous independent studies showing that aerobic Mycobacterium Tuberculosis limits the growth of anaerobic species Prevotella. Sandeep's hypothesis says this might be one of the main reasons for India’s apparent low numbers of severe cases/ deaths due to COVID19 in India - his exclusive interview with Dental Tribune South Asia.